FOS and nasopharyngeal carcinoma: In the present study, ZLMP110-277 and ZLMP277-110 blocked the activation of the MEK/ERK/p90RSK downstream signaling pathway and inhibited nuclear translocation of c-Fos and c-Myc expression in NPC cell lines.